Abstract
Purpose
It is not clear to what extent signs and symptoms other than arm swelling, including pain, altered sensory function, and body perception disturbances, differ between women with measurable and non-measurable breast cancer–related lymphedema (BCRL). A case-control study was performed to compare these signs and symptoms between (1) women with self-reported BCRL with objectively measurable swelling; (2) women with self-reported BCRL without objective confirmation; and (3) a control group with no self-reported BCRL.
Methods
The three groups were compared for (1) the severity of self-reported signs and symptoms of BCRL, (2) problems in functioning related to BCRL, (3) pain-related outcomes, (4) sensory functions, and (5) body perception.
Results
All self-reported outcomes related to signs and symptoms of BCRL and problems in functioning were significantly different between the control group and the other two groups with and without measurable self-reported BCRL (p < 0.001–0.003). Except for “skin texture” (p = 0.01), “hand swelling” (p=0.301) and ‘difficulty writing’ (p=0.676), no differences were found between groups. For pain-related outcomes, sensory function, and body perception, significant differences were only found for the mechanical detection threshold (p < 0.01) and self-reported disturbances in body perception (p < 0.001) between the self-reported BCRL groups and control group.
Conclusions
Diverse signs and symptoms related to BCRL, sensory function, and perception were different among women with self-reported BCRL compared to controls. No differences between women with and without measurable self-reported BCRL were found.
Implications for Cancer Survivors
The presence of self-reported BCRL, with or without measurable swelling, is a first indication for the need of further diagnostic evaluation.
Similar content being viewed by others
Change history
30 October 2021
A Correction to this paper has been published: https://doi.org/10.1007/s11764-021-01125-4
References
Disipio T, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15.
Gebruers N, et al. Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: a best practice guideline. Eur J Obstet Gynecol Reprod Biol. 2017;216:245–53.
Damstra RJ, et al. The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model. J Vasc Surg Venous Lymphat Disord. 2017;5(5):756–65.
Gursen C, et al. Self-reported signs and symptoms of secondary upper limb lymphoedema related to breast cancer treatment: systematic review. Eur J Cancer Care (Engl). 2021. https://doi.org/10.1111/ecc.13440.
Michelotti A, et al. Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management. Breast. 2019;44:15–23.
Armer J. Upper limb swelling following mastectomy: lymphedema or not? Oncology (Williston Park). 2007;21(4 Suppl):26–8.
Armer JM, et al. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52(6):370–9.
Bani HA, et al. Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns. 2007;66(3):311–8.
Fu MR, et al. Symptom report in detecting breast cancer-related lymphedema. Breast Cancer (Dove Med Press). 2015;7:345–52.
Mak SS, et al. Lymphedema and quality of life in Chinese women after treatment for breast cancer. Eur J Oncol Nurs. 2009;13(2):110–5.
Stubblefield MD, Keole N. Upper body pain and functional disorders in patients with breast cancer. PM R. 2013;6(2):170–83.
Stubblefield MD, Keole N. Upper body pain and functional disorders in patients with breast cancer. PM R. 2014;6(2):170–83.
Crosbie J, et al. Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement. Phys Ther. 2010;90(5):679–92.
De Groef A, et al. Unraveling self-reported signs of central sensitization in breast cancer survivors with upper limb pain: prevalence rate and contributing factors. Pain Physician. 2018;21(3):E247-e256.
Goldberg JI, et al. Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema. Ann Surg Oncol. 2011;18(10):2866–72.
Terada M, et al. Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors. Breast Cancer Res Treat. 2020;179(1):91–100.
Sayko O, et al. Diagnosis and treatment of lymphedema after breast cancer: a population-based study. Pm & R. 2013;5(11):915–23.
McLaughlin SA, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26(32):5220–6.
Hayes SC, et al. Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema. Lymphology. 2010;43(4):178–87.
Teo I, et al. Examining pain, body image, and depressive symptoms in patients with lymphedema secondary to breast cancer. Psycho-Oncology. 2015;24(11):1377–83 (Date of Publication: 01 Nov, 2015).
Lewis JS, et al. Body perception disturbance: a contribution to pain in complex regional pain syndrome (CRPS). Pain. 2007;133(1–3):111–9.
von Elm E, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.
De Groef A, et al. Reliability and validity of a Dutch Lymphoedema Questionnaire: cross-cultural validation of the Norman Questionnaire. Eur J Cancer Care (Engl). 2020;29(4):e13242.
De Vrieze T, et al. Revision of the Lymphedema Functioning, Disability and Health Questionnaire for Upper Limb Lymphedema (Lymph-ICF-UL): reliability and validity. Lymphat Res Biol. 2019;17(3):347–55.
Taylor R, et al. Reliability and validity of arm volume measurements for assessment of lymphedema. Phys Ther. 2006;86(2):205–14.
Gebruers N, et al. Volumetric evaluation of upper extremities in 250 healthy persons. Clin Physiol Funct Imaging. 2007;27(1):17–22.
Kahl C, Cleland JA. Visual analogue scale, numeric pain rating scale and the McGill pain Questionnaire: an overview of psychometric properties. Physical Therapy Reviews. 2005;10(2):123–8.
Poquet N, Lin C. The Brief Pain Inventory (BPI). J Physiother. 2016;62(1):52.
VanDenKerkhof EG, et al. Sensitivity of the DN4 in screening for neuropathic pain syndromes. Clin J Pain. 2018;34(1):30–6. https://doi.org/10.1097/AJP.0000000000000512.
Rolke R, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006;123(3):231–43.
Mucke MCH, Radbruch L, Baron R, Maier C, Tolle T, Treede RD, Rolke R, Quantitative sensory testing (QST). English version. Schmerz. 2016. https://doi.org/10.1007/s00482-015-0093-2.
Rolke RMW, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain. 2006;10(1):77–88.
Vilholm OJ, et al. Sensory function and pain in a population of patients treated for breast cancer. Acta Anaesthesiol Scand. 2009;53(6):800–6.
Norman SA, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27(3):390–7.
Norman SA, et al. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther. 2001;81(6):1192–205.
Brunelle CL, et al. Integrating symptoms into the diagnostic criteria for breast cancer-related lymphedema: applying results from a prospective surveillance program. Phys Ther. 2020;100(12):2186–97.
Cornish BH, et al. Early diagnosis of lymphedema in postsurgery breast cancer patients. Ann N Y Acad Sci. 2000;904:571–5.
Barrio AV, Eaton A, Frazier TG. A prospective validation study of bioimpedance with volume displacement in early-stage breast cancer patients at risk for lymphedema. Annals of surgical oncology. 2015;22(Suppl 3(03)):370–5.
Dylke ES, et al. Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol. 2016;55(12):1477–83.
Mihara M, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PLoS ONE [Electronic Resource]. 2012;7(6):e38182.
Dams L, et al. Quantitative sensory testing in women after surgery for breast cancer: a systematic review and narrative synthesis. Clin J Pain. 2021;37(7):538–64.
Baran E, et al. Upper limb sensory evaluations and ultrasonographic skin measurements in breast cancer-related lymphedema receiving complex decongestive physiotherapy. Support Care Cancer. 2021:1–9. https://doi.org/10.1007/s00520-021-06235-4.
Morales-Sánchez L, et al. Enhancing self-esteem and body image of breast cancer women through interventions: a systematic review. Int Environ Res Public Health. 2021;18(4). https://doi.org/10.3390/ijerph18041640.
Harvie DS, Edmond-Hank G, Smith AD. Tactile acuity is reduced in people with chronic neck pain. Musculoskelet Sci Pract. 2018;33:61–6.
Heathcote LC, Eccleston C. Pain and cancer survival: a cognitive-affective model of symptom appraisal and the uncertain threat of disease recurrence. Pain. 2017;158(7):1187–91.
Ghaffari F, et al. Patient-centred communication for women with breast cancer: Relation to body image perception. J Clin Nurs. 2020;29(23–24):4674–84.
Nijs J, et al. Pain following cancer treatment: guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain. Acta Oncol. 2016;55(6):659–63.
Wang L, et al. Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies. Br J Anaesth. 2020;125(3):346–57.
Mustonen L, et al. What makes surgical nerve injury painful? A 4-year to 9-year follow-up of patients with intercostobrachial nerve resection in women treated for breast cancer. Pain. 2019;160(1):246–56.
Starkweather A, Lyon D, Schubert C. Pain and inflammation in women with early-stage breast cancer prior to induction of chemotherapy. Biol Res Nurs. 2011;15(2):234–41.
Torres Lacomba M, et al. Incidence of myofascial pain syndrome in breast cancer surgery: a prospective study. Clin J Pain. 2010;26(4):320–5.
De Groef A, et al. Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial. Clin Rehabil. 2018;32(4):451–61.
Edwards RR, et al. Alteration in pain modulation in women with persistent pain after lumpectomy: influence of catastrophizing. Journal of Pain & Symptom Management. 2013;46(1):30-42 13p.
Verbelen H, et al. Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review. Breast Cancer Res Treat. 2014;144(1):21–31.
Temple LK, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol. 2002;9(7):654–62.
Svensson BJ, et al. Screening for breast cancer-related lymphoedema: self-assessment of symptoms and signs. Support Care Cancer. 2020;28(7):3073–80.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Groef, A., Devoogdt, N., Gursen, C. et al. Sensory signs and symptoms in women with self-reported breast cancer–related lymphedema: a case–control study close up. J Cancer Surviv 16, 1096–1106 (2022). https://doi.org/10.1007/s11764-021-01100-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-021-01100-z